Articles related to CLINICAL TRIALS

The recent PALISADE-2 trial has revealed promising results for fasedienol nasal spray in treating social anxiety disorder. Explore the significant findings and potential implications for future anxiety treatments.

Explore the findings of the A041702 study, presented at the ASCO annual meeting, which investigated the efficacy of two treatment regimens for older patients with CLL. The results, significantly influenced by COVID-19, call for further investigation and long-term follow-up to determine the potential benefits and risks.

The recent study on bevacizumab’s effect on ovarian cancer progression provides valuable insights into its initial benefits and subsequent risks.

This phase 2 trial demonstrates the potential of perioperative nivolumab combined with chemotherapy in achieving higher pathological complete response and survival rates in stage III NSCLC. Explore the detailed findings to understand how this approach may influence future treatment paradigms.

Recent phase 3 clinical trials have demonstrated the eye-opening potential of MDMA in the treatment of PTSD when paired with psychotherapy, providing a new method of patient care.

Recent phase 2 trials have explored VX-548, a selective inhibitor of NaV1.8, in managing acute post-surgical pain. Dive deeper into the study’s findings and its implications for pain management.